COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ study #218 of 237
12/22 Late treatment study
Cangiano et al., Aging, doi:10.18632/aging.202307 (Peer Reviewed)
Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests
Source   PDF   Share   Tweet
73% lower mortality with HCQ. Analysis of 98 PCR+ nursing home residents in Italy, mean age 90, showing HCQ mortality RR 0.27, p = 0.03. Subject to confounding by contraindication. The paper provides the p value for regression but not the effect size.

Cangiano et al., 12/22/2020, retrospective, Italy, Europe, peer-reviewed, 14 authors.
risk of death, 73.4% lower, RR 0.27, p = 0.03, treatment 5 of 33 (15.2%), control 37 of 65 (56.9%).
Details of all 237 studies    Meta analysis
Please send us corrections, updates, or comments.